Piezo1 activation using Yoda1 inhibits macropinocytosis in A431 human epidermoid carcinoma cells

Masashi Kuriyama1, Hisaaki Hirose2, Toshihiro Masuda1

  • 1Institute for Chemical Research, Kyoto University, Uji, Kyoto, 611-0011, Japan.

Scientific Reports
|April 16, 2022
PubMed

Insights

Yoda1, a Piezo1 agonist, inhibits macropinocytosis in Ras-transformed cancer cells by blocking membrane ruffling. This novel approach targets calcium influx and potassium channels, offering a potential cancer therapy strategy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Macropinocytosis is crucial for Ras-transformed cancer cells to acquire amino acids for survival.
  • Inhibiting macropinocytosis presents a promising therapeutic strategy for cancer treatment.
  • Specific inhibitors for macropinocytosis are currently limited.

Purpose of the Study:

  • To investigate the role of the mechanosensitive ion channel Piezo1 in regulating macropinocytosis.
  • To explore Yoda1, a Piezo1 agonist, as a potential inhibitor of cancer cell macropinocytosis.

Main Methods:

  • Utilized Yoda1, a Piezo1 agonist, to study its effect on epidermal growth factor (EGF)-induced macropinocytosis.
  • Investigated the dependence of Yoda1's inhibitory effect on extracellular calcium (Ca2+) influx via Piezo1.
  • Examined the involvement of the calcium-activated potassium channel KCa3.1 in the observed inhibition.

Main Results:

  • Yoda1 potently inhibited EGF-induced macropinocytosis.
  • The inhibition of membrane ruffling by Yoda1 was dependent on extracellular Ca2+ influx through Piezo1.
  • Yoda1's effect involved the activation of the KCa3.1 channel, indicating Ca2+ regulation of macropinocytosis.

Conclusions:

  • Chemical modulation of mechanosensitive channels, like Piezo1, can inhibit macropinocytosis.
  • This study highlights a novel mechanism for regulating macropinocytosis via ion channel activity.
  • Targeting Piezo1 and associated ion channels offers a potential new avenue for cancer therapy.

Related Concept Videos

Mechanism of Filopodia Formation01:39

Mechanism of Filopodia Formation

Filopodia are thin, actin-rich cellular protrusions that play an important role in many fundamental cellular functions. They vary in their occurrence, length, and positioning in different cell types, suggesting their diverse roles.
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
2.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K